← Evidence map

ArticleMolecular therapy. Methods & clinical development2025

CRISPR/methotrexate-integrated strategy for TCR-T cell engineering with reduced chromosome 14 loss.

Jian Xu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

Not cited yet

Full record →Abstract, authors, funding and every citing paper · PMID 41376778